These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 18595727)

  • 1. Serum and tissue biomarkers as predictive and prognostic variables in epithelial ovarian cancer.
    Gadducci A; Cosio S; Tana R; Genazzani AR
    Crit Rev Oncol Hematol; 2009 Jan; 69(1):12-27. PubMed ID: 18595727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carboxyterminal telopeptide of type I collagen (ICTP) in predicting prognosis in epithelial ovarian cancer.
    Simojoki M; Santala M; Risteli J; Kauppila A
    Gynecol Oncol; 2001 Jul; 82(1):110-5. PubMed ID: 11426971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The CA-125 tumor marker in epithelial ovarian cancers of stage I].
    Nagele F; Vavra N; Kurz C; Sevelda P
    Wien Klin Wochenschr; 1993; 105(20):585-8. PubMed ID: 8259686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VEGF-A and i-NOS expression are prognostic factors in serous epithelial ovarian carcinomas after complete surgical resection.
    Engels K; du Bois A; Harter P; Fisseler-Eckhoff A; Kommoss F; Stauber R; Kaufmann M; Nekljudova V; Loibl S
    J Clin Pathol; 2009 May; 62(5):448-54. PubMed ID: 19126566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue and serum biomarkers as prognostic variables in endometrioid-type endometrial cancer.
    Gadducci A; Cosio S; Genazzani AR
    Crit Rev Oncol Hematol; 2011 Nov; 80(2):181-92. PubMed ID: 21134766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tumor markers in epithelial ovarian cancer].
    Di Cocco B; Calabretta F; Alghisi F; Salesi N; Bossone G
    Minerva Ginecol; 2003 Aug; 55(4):327-32. PubMed ID: 14581857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and prognostic significance of kallikrein-related peptidase 8 protein levels in advanced ovarian cancer by using automated quantitative analysis.
    Kountourakis P; Psyrri A; Scorilas A; Markakis S; Kowalski D; Camp RL; Diamandis EP; Dimopoulos MA
    Thromb Haemost; 2009 Mar; 101(3):541-6. PubMed ID: 19277417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating tumour markers in ovarian tumours.
    von Schlippe M; Rustin GJ
    Forum (Genova); 2000; 10(4):383-92. PubMed ID: 11535987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cdc7 kinase is a predictor of survival and a novel therapeutic target in epithelial ovarian carcinoma.
    Kulkarni AA; Kingsbury SR; Tudzarova S; Hong HK; Loddo M; Rashid M; Rodriguez-Acebes S; Prevost AT; Ledermann JA; Stoeber K; Williams GH
    Clin Cancer Res; 2009 Apr; 15(7):2417-25. PubMed ID: 19318489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multiparametric panel for ovarian cancer diagnosis, prognosis, and response to chemotherapy.
    Zheng Y; Katsaros D; Shan SJ; de la Longrais IR; Porpiglia M; Scorilas A; Kim NW; Wolfert RL; Simon I; Li L; Feng Z; Diamandis EP
    Clin Cancer Res; 2007 Dec; 13(23):6984-92. PubMed ID: 18056174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of serum CA125 with stage, grade and survival of patients with epithelial ovarian cancer at a single centre.
    Osman N; O'Leary N; Mulcahy E; Barrett N; Wallis F; Hickey K; Gupta R
    Ir Med J; 2008 Sep; 101(8):245-7. PubMed ID: 18990955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor D and intratumoral lymphatics as independent prognostic factors in epithelial ovarian carcinoma.
    Li L; Liu B; Li X; Yang S; Xiao J; Chen M; Zhang Y; Ma J
    Anat Rec (Hoboken); 2009 Apr; 292(4):562-9. PubMed ID: 19226617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma.
    Gilks CB; Ionescu DN; Kalloger SE; Köbel M; Irving J; Clarke B; Santos J; Le N; Moravan V; Swenerton K;
    Hum Pathol; 2008 Aug; 39(8):1239-51. PubMed ID: 18602670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognostic and predictive factors in epithelial ovarian cancer].
    Boudou-Rouquette P; Pautier P; Morice P; Lhommé C
    Bull Cancer; 2009 Apr; 96(4):425-37. PubMed ID: 19357017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Identification of new ovarian cancer biomarkers with proteomic analyses--the diagnostic tool of the future?].
    Petri AL; Høgdall E; Engelholm SA; Christensen IJ; Kjaer SK; Høgdall CK
    Ugeskr Laeger; 2007 Aug; 169(33):2614-9. PubMed ID: 17725906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic factors in ovarian carcinoma].
    Hauptmann S; Köbel M
    Verh Dtsch Ges Pathol; 2005; 89():92-100. PubMed ID: 18035678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of preoperative serum CA-125 levels in the prediction of lymph node metastasis in epithelial ovarian cancer.
    Kim HS; Park NH; Chung HH; Kim JW; Song YS; Kang SB
    Acta Obstet Gynecol Scand; 2008; 87(11):1136-42. PubMed ID: 18951217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of proteomics in ovarian cancer: which sample should be used?
    Cadron I; Van Gorp T; Timmerman D; Amant F; Waelkens E; Vergote I
    Gynecol Oncol; 2009 Dec; 115(3):497-503. PubMed ID: 19811810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological markers and prognosis in recurrent oral cancer after salvage surgery.
    Agra IM; Carvalho AL; Pinto CA; Martins EP; Filho JG; Soares FA; Kowalski LP
    Arch Otolaryngol Head Neck Surg; 2008 Jul; 134(7):743-9. PubMed ID: 18645125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Large-scale proteomics analysis of human ovarian cancer for biomarkers.
    Bengtsson S; Krogh M; Szigyarto CA; Uhlen M; Schedvins K; Silfverswärd C; Linder S; Auer G; Alaiya A; James P
    J Proteome Res; 2007 Apr; 6(4):1440-50. PubMed ID: 17315909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.